Investing.com - IGM Biosciences reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
IGM Biosciences announced earnings per share of $-1.32 on revenue of $331.0K. Analysts polled by Investing.com anticipated EPS of $-1.38 on revenue of $278.86K.
IGM Biosciences shares are down 58% from the beginning of the year and are trading at $16.50 , down-from-52-week-high.
IGM Biosciences follows other major Healthcare sector earnings this month
IGM Biosciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar